OP81 Outcome-Based Managed Entry Agreements For Rare Disease Therapies: Learnings From The Belgian Experience.

Saved in:
Bibliographic Details
Title: OP81 Outcome-Based Managed Entry Agreements For Rare Disease Therapies: Learnings From The Belgian Experience.
Authors: Blonda, Alessandra, alessandra.blonda@kuleuven.be, Facey, Karen, Van de Vijver, Inneke, Denier, Yvonne, Huys, Isabelle, Simoens, Steven
Source: International Journal of Technology Assessment in Health Care; 2025 Supplement, Vol. 41, pS37-S37, 1p
Database: Applied Science & Technology Source
Description
ISSN:02664623
DOI:10.1017/S0266462325101359